| [604] | 1 | English French  Notes   Complete/Exclude | 
|---|
|  | 2 | ABDOMINAL INFECTION..............: NA, no treatment | 
|---|
|  | 3 | ABSCESS..........................: NA, no treatment | 
|---|
|  | 4 | ADMISSION FOR NEUTROPENIA........: NA, no treatment | 
|---|
|  | 5 | ANASTOMOTIC DEHISCENCE...........: NA, no treatment | 
|---|
|  | 6 | BLEEDING/HEMATOMA................: NA, no treatment | 
|---|
|  | 7 | DEHYDRATION......................: NA, no treatment | 
|---|
|  | 8 | DIARRHEA.........................: NA, no treatment | 
|---|
|  | 9 | EARLY BOWEL OBSTRUCTION..........: NA, no treatment | 
|---|
|  | 10 | PERINEAL INFECTION...............: NA, no treatment | 
|---|
|  | 11 | PNEUMONIA........................: NA, no treatment | 
|---|
|  | 12 | PROCTITIS........................: NA, no treatment | 
|---|
|  | 13 | PULMONARY EMBOLISM...............: NA, no treatment | 
|---|
|  | 14 | RADIATION ENTERITIS..............: NA, no treatment | 
|---|
|  | 15 | STOMA COMPLICATION...............: NA, no treatment | 
|---|
|  | 16 | URINARY TRACT INFECTION..........: NA, no treatment | 
|---|
|  | 17 | POSTOPERATIVE DEATH W/I 30 DAYS: NA, no surgery | 
|---|
|  | 18 | 763  ADDITIONAL SURGICAL PROCEDURES.. | 
|---|
|  | 19 | 764  LAPAROSCOPY USED DURING SURGERY. | 
|---|
|  | 20 | 765  METHOD OF ANASTOMOSIS........... | 
|---|
|  | 21 | 766  DIST OF ANASTOMOSIS FROM DENTATE | 
|---|
|  | 22 | 59  RESIDUAL PRIMARY TUMOR.......... | 
|---|
|  | 23 | 769    PATHOLOGICAL STATUS........... | 
|---|
|  | 24 | 770    ABDOMINAL INFECTION........... | 
|---|
|  | 25 | 772    ADMISSION FOR NEUTROPENIA..... | 
|---|
|  | 26 | 773    ANASTOMOTIC DEHISCENCE........ | 
|---|
|  | 27 | 776    EARLY BOWEL OBSTRUCTION....... | 
|---|
|  | 28 | 777    PERINEAL INFECTION............ | 
|---|
|  | 29 | 780    PULMONARY EMBOLISM............ | 
|---|
|  | 30 | 781    RADIATION ENTERITIS........... | 
|---|
|  | 31 | 782    STOMA COMPLICATION............ | 
|---|
|  | 32 | 783    URINARY TRACT INFECTION....... | 
|---|
|  | 33 | 441  POSTOPERATIVE DEATH W/I 30 DAYS. | 
|---|
|  | 34 | DATE RADIATION STARTED..........: | 
|---|
|  | 35 | DATE RADIATION THERAPY ENDED....: 00/00/0000 | 
|---|
|  | 36 | ENDOCAVITARY RADIATION..........: None | 
|---|
|  | 37 | INTRA-OPERATIVE RAD THERAPY.....: No | 
|---|
|  | 38 | PRIMARY TUMOR RAD DOSE W BOOST..: No radiation therapy | 
|---|
|  | 39 | NUMBER OF RADIATION TREATMENTS..: None | 
|---|
|  | 40 | DATE RADIATION THERAPY ENDED....: 99/99/9999 | 
|---|
|  | 41 | ENDOCAVITARY RADIATION..........: Unknown | 
|---|
|  | 42 | INTRA-OPERATIVE RAD THERAPY.....: Unknown | 
|---|
|  | 43 | PRIMARY TUMOR RAD DOSE W BOOST..: Unknown if received radiation therapy | 
|---|
|  | 44 | NUMBER OF RADIATION TREATMENTS..: Unknown if radiation given | 
|---|
|  | 45 | 361  DATE RADIATION THERAPY ENDED.... | 
|---|
|  | 46 | 784  ENDOCAVITARY RADIATION.......... | 
|---|
|  | 47 | 785  INTRA-OPERATIVE RAD THERAPY..... | 
|---|
|  | 48 | 786  PRIMARY TUMOR RAD DOSE W BOOST.. | 
|---|
|  | 49 | 787  NUMBER OF RADIATION TREATMENTS.. | 
|---|
|  | 50 | DATE CHEMOTHERAPY STARTED.......: | 
|---|
|  | 51 | ADJUVANT CHEMO W BEAM RADIATION.: No concomitant treatment | 
|---|
|  | 52 | ADJUVANT THERAPY: | 
|---|
|  | 53 | DURATION OF ADJUVANT THERAPY....: No adjuvant therapy | 
|---|
|  | 54 | COMPLETED DURATION OF THERAPY...: No (0-1 cycle) | 
|---|
|  | 55 | ADJUVANT CHEMO W BEAM RADIATION.: Unknown if therapy concomitant | 
|---|
|  | 56 | DURATION OF ADJUVANT THERAPY....: Unknown if therapy given | 
|---|
|  | 57 | COMPLETED DURATION OF THERAPY...: Unknown if therapy given | 
|---|
|  | 58 | 788  ADJUVANT CHEMO W BEAM RADIATION. | 
|---|
|  | 59 | 794  DURATION OF ADJUVANT THERAPY.... | 
|---|
|  | 60 | 795  COMPLETED DURATION OF THERAPY... | 
|---|
|  | 61 | WERE OTHER REFERRALS MADE | 
|---|
|  | 62 | TABLE V - QUALITY OF LIFE | 
|---|
|  | 63 | WERE OTHER REFERRALS MADE: | 
|---|
|  | 64 | 796  NUTRITIONAL CONSULTATION | 
|---|
|  | 65 | 797  OCCUPATIONAL THERAPY.... | 
|---|
|  | 66 | 563  PHYSICAL THERAPY........ | 
|---|
|  | 67 | 798  OSTOMY CONSULTATION..... | 
|---|
|  | 68 | 70DATE OF FIRST RECURRENCE...... | 
|---|
|  | 69 | 71TYPE OF FIRST RECURRENCE...... | 
|---|
|  | 70 | DATE OF LAST CONTACT OR DEATH: | 
|---|
|  | 71 | 15VITAL STATUS................. | 
|---|
|  | 72 | CANCER STATUS................: | 
|---|
|  | 73 | 81COMPLETED BY................. | 
|---|
|  | 74 | 82REVIEWED BY CANCER COMMITTEE. | 
|---|
|  | 75 | 10. FAMILY HISTORY OF COLORECTAL CA..: | 
|---|
|  | 76 | 11. PERSONAL HISTORY OF COLORECTAL CA: | 
|---|
|  | 77 | 12. MULTI 1997 COLON/RECTUM PRIMARIES: | 
|---|
|  | 78 | 13. PERSONAL HISTORY OF NON-COLORECTAL CANCER: | 
|---|
|  | 79 | PROSTATE.........: | 
|---|
|  | 80 | STOMACH..........: | 
|---|
|  | 81 | THYROID..........: | 
|---|
|  | 82 | UTERUS...........: | 
|---|
|  | 83 | OVARIAN CARCINOMA: | 
|---|
|  | 84 | OTHER............: | 
|---|
|  | 85 | 14. PREVIOUS TAH/BSO.................: | 
|---|
|  | 86 | 15. OTHER PRIOR CONDITIONS: | 
|---|
|  | 87 | PRIOR POLYPS.....: | 
|---|
|  | 88 | POLYPS...........: | 
|---|
|  | 89 | 17. DURATION OF SIGNS/SYMPTOMS PRESENT AT INITIAL DIAGNOSIS (months): | 
|---|
|  | 90 | BOWEL OBSTRUCTION..............: | 
|---|
|  | 91 | CHANGE IN BOWEL HABIT..........: | 
|---|
|  | 92 | EMER PRESENTATION-OBSTRUCTION..: | 
|---|
|  | 93 | OCCULT BLOOD ONLY IN STOOL.....: | 
|---|
|  | 94 | RECTAL BLEEDING (MELENA).......: | 
|---|
|  | 95 | 18. INITIAL METHODS OF DIAGNOSIS: | 
|---|
|  | 96 | SCREENING DIGITAL RECTAL EXAM..: | 
|---|
|  | 97 | SCREENING PHYSICAL EXAM........: | 
|---|
|  | 98 | 19. REASON LEADING TO EVENTUAL DX....: | 
|---|
|  | 99 | 20. DIAGNOSTIC EVALUATION: | 
|---|
|  | 100 | BARIUM ENEMA, DOUBLE CONTRAST..: | 
|---|
|  | 101 | BARIUM ENEMA, SINGLE CONTRAST..: | 
|---|
|  | 102 | BARIUM ENEMA, NOS..............: | 
|---|
|  | 103 | BIOPSY OF PRIMARY SITE.........: | 
|---|
|  | 104 | BIOPSY OF METASTATIC SITE......: | 
|---|
|  | 105 | CT SCAN OF CHEST...............: | 
|---|
|  | 106 | CT SCAN OF LIVER...............: | 
|---|
|  | 107 | CT SCAN OF PRIMARY SITE........: | 
|---|
|  | 108 | CHEST ROENTGENOGRAM............: | 
|---|
|  | 109 | DIGITAL RECTAL EXAM............: | 
|---|
|  | 110 | FLEXIBLE SIGMOIDOSCOPY.........: | 
|---|
|  | 111 | INTRAVENOUS PYELOGRAM..........: | 
|---|
|  | 112 | SERUM-LIVER FUNCTION TEST......: | 
|---|
|  | 113 | STOOL GUAIAC (OCCULT BLOOD)....: | 
|---|
|  | 114 | 21. LEVEL OF TUMOR BY ENDOSCOPIC EXAM: | 
|---|
|  | 115 | 22. LEVEL OF RECTAL TUMOR............: | 
|---|
|  | 116 | 23. DATE OF INITIAL DIAGNOSIS........: | 
|---|
|  | 117 | 24. PRIMARY SITE.....................: | 
|---|
|  | 118 | 25. HISTOLOGY/26. BEHAVIOR CODE......: | 
|---|
|  | 119 | 28. DIAGNOSTIC CONFIRMATION..........: | 
|---|
|  | 120 | Print Colorectal Cancer PCE | 
|---|
|  | 121 | PCE Study of Colorectal Cancer | 
|---|
|  | 122 | 29. SIZE OF TUMOR (mm)...............: | 
|---|
|  | 123 | 30. REGIONAL NODES EXAMINED..........: | 
|---|
|  | 124 | 31. REGIONAL NODES POSITIVE..........: | 
|---|
|  | 125 | 32. AJCC CLINICAL STAGE (cTNM): | 
|---|
|  | 126 | AJCC STAGE.....................: | 
|---|
|  | 127 | 33. AJCC PATHOLOGIC STAGE (pTNM): | 
|---|
|  | 128 | 34. STAGED BY: | 
|---|
|  | 129 | CLINICAL STAGE.................: | 
|---|
|  | 130 | PATHOLOGIC STAGE...............: | 
|---|
|  | 131 | 35. MARGIN OF RESECTION: | 
|---|
|  | 132 | PROXIMAL MARGIN................: | 
|---|
|  | 133 | DISTAL MARGIN..................: | 
|---|
|  | 134 | RADIAL MARGIN..................: | 
|---|
|  | 135 | 36. DISTANCE TO MUCOSAL MARGIN.......: | 
|---|
|  | 136 | 37. DISTANCE TO RADIAL MARGIN........: | 
|---|
|  | 137 | 38. BLOOD VESSEL/LYMPHATIC INVASION..: | 
|---|
|  | 138 | 39. EXTRAMURAL VENOUS INVASION.......: | 
|---|
|  | 139 | 40. PROMINENT LYMPHOID INFILTRATE....: | 
|---|
|  | 140 | 41. PHYSICIAN PROVIDING TREATMENT....: | 
|---|
|  | 141 | 42. FIRST COURSE OF TREATMENT DATE...: | 
|---|
|  | 142 | 43. DATE OF INPATIENT ADMISSION......: | 
|---|
|  | 143 | 44. DATE OF INPATIENT DISCHARGE......: | 
|---|
|  | 144 | 45. NON CANCER-DIRECTED SURGERY DATE.: | 
|---|
|  | 145 | 46. NON CANCER-DIRECTED SURGERY......: | 
|---|
|  | 146 | 47. SURGERY OF PRIMARY SITE DATE.....: | 
|---|
|  | 147 | 48. SURGERY OF PRIMARY SITE..........: | 
|---|
|  | 148 | 49. ADDITIONAL SURGICAL PROCEDURES...: | 
|---|
|  | 149 | 50. LAPAROSCOPY USED DURING SURGERY..: | 
|---|
|  | 150 | 51. METHOD OF ANASTOMOSIS............: | 
|---|
|  | 151 | 52. DIST OF ANASTOMOSIS FROM DENTATE.: | 
|---|
|  | 152 | 53. RESIDUAL PRIMARY TUMOR...........: | 
|---|
|  | 153 | 54. OTHER SURGERY: | 
|---|
|  | 154 | PATHOLOGICAL STATUS............: | 
|---|
|  | 155 | 55. COMPLICATIONS AFTER FIRST COURSE OF TREATMENT: | 
|---|
|  | 156 | ABDOMINAL INFECTION......: | 
|---|
|  | 157 | PERINEAL INFECTION.......: | 
|---|
|  | 158 | PNEUMONIA................: | 
|---|
|  | 159 | ADMISSION FOR NEUTROPENIA: | 
|---|
|  | 160 | PROCTITIS................: | 
|---|
|  | 161 | ANASTOMOTIC DEHISCENCE...: | 
|---|
|  | 162 | PULMONARY EMBOLISM.......: | 
|---|
|  | 163 | RADIATION ENTERITIS......: | 
|---|
|  | 164 | STOMA COMPLICATION.......: | 
|---|
|  | 165 | URINARY TRACT INFECTION..: | 
|---|
|  | 166 | EARLY BOWEL OBSTRUCTION..: | 
|---|
|  | 167 | 56. POSTOPERATIVE DEATH W/I 30 DAYS: | 
|---|
|  | 168 | 57. DATE RADIATION STARTED...........: | 
|---|
|  | 169 | 58. DATE RADIATION THERAPY ENDED.....: | 
|---|
|  | 170 | 59. ENDOCAVITARY RADIATION...........: | 
|---|
|  | 171 | 60. INTRA-OPERATIVE RAD THERAPY......: | 
|---|
|  | 172 | 61. PRIMARY TUMOR RAD DOSE W BOOST...: | 
|---|
|  | 173 | 62. NUMBER OF RADIATION TREATMENTS...: | 
|---|
|  | 174 | 64. DATE CHEMOTHERAPY STARTED........: | 
|---|
|  | 175 | 65. ADJUVANT CHEMO W BEAM RADIATION..: | 
|---|
|  | 176 | 66. ADJUVANT THERAPY: | 
|---|
|  | 177 | CPT 11.............: | 
|---|
|  | 178 | TAXOL..............: | 
|---|
|  | 179 | OTHER..............: | 
|---|
|  | 180 | 67. DURATION OF ADJUVANT THERAPY.....: | 
|---|
|  | 181 | 68. COMPLETED DURATION OF THERAPY....: | 
|---|
|  | 182 | 69. WERE OTHER REFERRALS MADE: | 
|---|
|  | 183 | NUTRITIONAL CONSULTATION.......: | 
|---|
|  | 184 | OCCUPATIONAL THERAPY...........: | 
|---|
|  | 185 | PHYSICAL THERAPY...............: | 
|---|
|  | 186 | OSTOMY CONSULTATION............: | 
|---|
|  | 187 | 70. DATE OF FIRST RECURRENCE..........: | 
|---|
|  | 188 | 71. TYPE OF FIRST RECURRENCE..........: | 
|---|
|  | 189 | 72. DATE OF LAST CONTACT OR DEATH....: | 
|---|
|  | 190 | 73. VITAL STATUS.....................: | 
|---|
|  | 191 | 74. CANCER STATUS....................: | 
|---|
|  | 192 | 75. COMPLETED BY.....................: | 
|---|
|  | 193 | 76. REVIEWED BY CANCER COMMITTEE.....: | 
|---|
|  | 194 | Deleting data from the following fields... | 
|---|
|  | 195 | SURGICAL DX/STAGING PROC | 
|---|
|  | 196 | SURGICAL DX/STAGING PROC DATE | 
|---|
|  | 197 | SURGERY OF PRIMARY (R) | 
|---|
|  | 198 | SURGICAL APPROACH (R) | 
|---|
|  | 199 | SURGERY OF PRIMARY (F) | 
|---|
|  | 200 | SURGERY OF PRIMARY DATE | 
|---|
|  | 201 | SURGICAL MARGINS | 
|---|
|  | 202 | DATE OF SURGICAL DISCHARGE | 
|---|
|  | 203 | REASON FOR NO SURGERY | 
|---|
|  | 204 | SURGERY OF PRIMARY SITE | 
|---|
|  | 205 | SURGERY OF PRIMARY SITE DATE | 
|---|
|  | 206 | SCOPE OF LN SURGERY (R) | 
|---|
|  | 207 | NUMBER OF LN REMOVED (R) | 
|---|
|  | 208 | SCOPE OF LN SURGERY (F) | 
|---|
|  | 209 | SCOPE OF LYMPH NODE SURG DATE | 
|---|
|  | 210 | SURG PROC/OTHER SITE (R) | 
|---|
|  | 211 | SURG PROC/OTHER SITE (F) | 
|---|
|  | 212 | SURG PROC/OTHER SITE DATE | 
|---|
|  | 213 | DATE RADIATION STARTED | 
|---|
|  | 214 | LOCATION OF RADIATION TX | 
|---|
|  | 215 | RADIATION TREATMENT VOLUME | 
|---|
|  | 216 | REGIONAL TREATMENT MODALITY | 
|---|
|  | 217 | REGIONAL DOSE:cGy | 
|---|
|  | 218 | BOOST TREATMENT MODALITY | 
|---|
|  | 219 | BOOST DOSE:cGy | 
|---|
|  | 220 | NUMBER OF TXS TO THIS VOLUME | 
|---|
|  | 221 | RADIATION/SURGERY SEQUENCE | 
|---|
|  | 222 | DATE RADIATION ENDED | 
|---|
|  | 223 | REASON FOR NO RADIATION | 
|---|
|  | 224 | TEXT-RX-RADIATION OTHER | 
|---|
|  | 225 | CHEMOTHERAPY DATE | 
|---|
|  | 226 | REASON FOR NO CHEMOTHERAPY | 
|---|
|  | 227 | HORMONE THERAPY | 
|---|
|  | 228 | HORMONE THERAPY DATE | 
|---|
|  | 229 | REASON FOR NO HORMONE THERAPY | 
|---|
|  | 230 | IMMUNOTHERAPY DATE | 
|---|
|  | 231 | HEMA TRANS/ENDOCRINE PROC | 
|---|
|  | 232 | HEMA TRANS/ENDOCRINE PROC DATE | 
|---|
|  | 233 | OTHER TREATMENT | 
|---|
|  | 234 | OTHER TREATMENT DATE | 
|---|
|  | 235 | PALLIATIVE PROCEDURE @FAC | 
|---|
|  | 236 | SURGICAL DX/STAGING @FAC | 
|---|
|  | 237 | SURGICAL DX/STAGING @FAC DATE | 
|---|
|  | 238 | SURGERY OF PRIMARY @FAC (R) | 
|---|
|  | 239 | SURGERY OF PRIMARY @FAC (F) | 
|---|
|  | 240 | SURGERY OF PRIMARY @FAC DATE | 
|---|
|  | 241 | SCOPE OF LN SURGERY @FAC (R) | 
|---|
|  | 242 | NUMBER OF LN REMOVED @FAC (R) | 
|---|
|  | 243 | SCOPE OF LN SURGERY @FAC (F) | 
|---|
|  | 244 | SCOPE OF LN SURGERY @FAC DATE | 
|---|
|  | 245 | SURG PROC/OTHER SITE @FAC (R) | 
|---|
|  | 246 | SURG PROC/OTHER SITE @FAC (F) | 
|---|
|  | 247 | SURG PROC/OTHER SITE @FAC DATE | 
|---|
|  | 248 | RADIATION @FAC DATE | 
|---|
|  | 249 | CHEMOTHERAPY @FAC DATE | 
|---|
|  | 250 | HORMONE THERAPY @FAC | 
|---|
|  | 251 | HORMONE THERAPY @FAC DATE | 
|---|
|  | 252 | IMMUNOTHERAPY @FAC DATE | 
|---|
|  | 253 | OTHER TREATMENT @FAC | 
|---|
|  | 254 | OTHER TREATMENT @FAC DATE | 
|---|
|  | 255 | STATE AT DX = YY ( | 
|---|
|  | 256 | POSTAL CODE AT DX must be 888888888 | 
|---|
|  | 257 | STATE AT DX = ZZ ( | 
|---|
|  | 258 | POSTAL CODE AT DX must be 999999999 | 
|---|
|  | 259 | REPORTING HOSPITAL = FACILITY REFERRED FROM | 
|---|
|  | 260 | REPORTING HOSPITAL = FACILITY REFERRED TO | 
|---|
|  | 261 | CLASS OF CASE = | 
|---|
|  | 262 | FACILITY REFERRED FROM may not be blank | 
|---|
|  | 263 | DATE OF FIRST CONTACT..: | 
|---|
|  | 264 | later than | 
|---|
|  | 265 | SURGERY OF PRIMARY SITE DATE.: | 
|---|
|  | 266 | RADIATION DATE...............: | 
|---|
|  | 267 | RADIATION THERAPY TO CNS DATE: | 
|---|
|  | 268 | CHEMOTHERAPY DATE............: | 
|---|
|  | 269 | HORMONE THERAPY DATE.........: | 
|---|
|  | 270 | IMMUNOTHERAPY DATE...........: | 
|---|
|  | 271 | OTHER TREATMENT DATE.........: | 
|---|
|  | 272 | earlier than | 
|---|
|  | 273 | DATE DX......................: | 
|---|
|  | 274 | TYPE OF REPORTING SOURCE = 6 ( | 
|---|
|  | 275 | CLASS OF CASE must be 5 (Dx at autopsy) | 
|---|
|  | 276 | CLASS OF CASE = 5 ( | 
|---|
|  | 277 | TYPE OF REPORTING SOURCE must be 6 (Autopsy only) | 
|---|
|  | 278 | TYPE OF REPORTING SOURCE = 7 ( | 
|---|
|  | 279 | DIAGNOSTIC CONFIRMATION must be 9 (Unk if microscopically confirmed) | 
|---|
|  | 280 | DIAGNOSTIC CONFIRMATION must be 1 (Pos histology) or | 
|---|
|  | 281 | 6 (Direct visualization) | 
|---|
|  | 282 | is a paired site | 
|---|
|  | 283 | LATERALITY must be provided for specified paired organs/sites | 
|---|
|  | 284 | NOTE: If NASAL CARTILAGE or NASAL SEPTUM, override this warning. | 
|---|
|  | 285 | NOTE: If CARINA, override this warning. | 
|---|
|  | 286 | NOTE: If STERNUM, override this warning. | 
|---|
|  | 287 | NOTE: If SACRUM, COCCYX or SYMPHYSIS PUBIS, override this warning. | 
|---|
|  | 288 | is an unpaired site | 
|---|
|  | 289 | LATERALITY must be 0 (Not a paired site) | 
|---|
|  | 290 | BEHAVIOR CODE = 2 (In situ) | 
|---|
|  | 291 | SUMMARY STAGE = | 
|---|
|  | 292 | BEHAVIOR CODE and SUMMARY STAGE confict | 
|---|
|  | 293 | BEHAVIOR CODE = 3 (Malignant) | 
|---|
|  | 294 | SUMMARY STAGE = 0 (In situ) | 
|---|
|  | 295 | HISTOLOGY = | 
|---|
|  | 296 | TYPE OF REPORTING SOURCE = | 
|---|
|  | 297 | SUMMARY STAGE must be 7 (Distant Mets/systemic disease) | 
|---|
|  | 298 | GRADE/DIFFERENTIATION must be 1 (Grade I) | 
|---|
|  | 299 | GRADE/DIFFERENTIATION must be 2 (Grade II) | 
|---|
|  | 300 | GRADE/DIFFERENTIATION must be 4 (Grade IV) | 
|---|
|  | 301 | GRADE/DIFFERENTIATION must be: 3 (Grade III) | 
|---|
|  | 302 | 7 (Null cell) | 
|---|
|  | 303 | ####################    ####################    #################### | 
|---|
|  | 304 | ####################    ####################    #################### | 
|---|
|  | 305 | ####################    ####################    #################### | 
|---|
|  | 306 | ####################    ####################    #################### | 
|---|
|  | 307 | ####################    ####################    #################### | 
|---|